Researchers developed a nasal antibody that blocks mugwort pollen, a major hay fever trigger in Europe and Central Asia.

Discover how Agilent's AssayMAP Bravo and RapidFire systems accelerate drug discovery with automation and rapid, reliable ...

At ASMS 2025, the Technology Networks team spoke with Chris Lock from SCIEX to discuss how improvements in proteomics ...

How concerned should we be about PFAS in our drinking water? Professor Rainer Lohmann answers this question and more.

Women diagnosed with premenstrual symptoms have a slightly increased risk of developing cardiovascular disease later in life.

The FDA has released 200+ complete response letters in a bid to offer new insights into drug approval rejections and ...

Technology Networks spoke with Stefan Foser, vice president of global pharma at Bruker, to explore how they integrate ...

A Weizmann Institute study has identified hundreds of B2-SINE RNA molecules that drive nerve regeneration in mice. These ...

In a world-first pilot study, researchers from the University of South Australia have used video footage of insects to ...

Adults who stay consistently active throughout their lives can lower their risk of early death by up to 40 percent, a global ...

A University of Colorado study has revealed that dopamine communicates with precise, targeted signals rather than flooding ...

The results offer real-world data that support long-term protection through vaccination and suggest a level of population ...